{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:31:54Z","timestamp":1784295114669,"version":"3.55.0"},"reference-count":90,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T00:00:00Z","timestamp":1487548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical Research Council, South Africa"},{"name":"National Research Foundation, South Africa"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Artemisinin and its derivatives have been reported to be experimentally effective for the treatment of highly aggressive cancers without developing drug resistance, they are useful for the treatment of malaria, other protozoal infections and they exhibit antiviral activity. However, they are limited pharmacologically by their poor bioavailability, short half-life in vivo, poor water solubility and long term usage results in toxicity. They are also expensive for the treatment of malaria when compared to other antimalarials. In order to enhance their therapeutic efficacy, they are incorporated onto different drug delivery systems, thus yielding improved biological outcomes. This review article is focused on the currently synthesized derivatives of artemisinin and different delivery systems used for the incorporation of artemisinin and its derivatives.<\/jats:p>","DOI":"10.3390\/molecules22020323","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T11:07:24Z","timestamp":1487588844000},"page":"323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["Design of Drug Delivery Systems Containing Artemisinin and Its Derivatives"],"prefix":"10.3390","volume":"22","author":[{"given":"Blessing","family":"Aderibigbe","sequence":"first","affiliation":[{"name":"Department of Chemistry, University of Fort Hare, Alice Campus, Eastern Cape 5700, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/clpt.2012.96","article-title":"Pharmacogenomics Knowledge for Personalized Medicine","volume":"92","author":"McDonagh","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1016\/j.bmc.2013.04.059","article-title":"Novel artemisinin derivatives with potential usefulness against liver\/colon cancer and viral hepatitis","volume":"21","author":"Blazquez","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"ref_3","unstructured":"Artemisinin Effects, Health Benefits and Uses. Available online: http:\/\/nootriment.com\/artemisinin\/."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/591195","article-title":"The antiviral activities of artemisinin and artesunate","volume":"47","author":"Efferth","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Loo, C.S., Lam, N.S., Yu, D., Su, X.Z., and Lu, F. (2016). Artemisinin and its derivatives in treating protozoan infections beyond malaria. Pharmacol. Res.","DOI":"10.1016\/j.phrs.2016.11.012"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.actatropica.2005.06.009","article-title":"Artemisinin-based combination therapies (ACTs): Best hope for malaria treatment but inaccessible to the needy","volume":"95","author":"Mutabingwa","year":"2005","journal-title":"Acta Trop."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1038\/ncomms6606","article-title":"Contrasting benefits of different artemisinin combination therapies as first-line malaria treatments using model-based cost-effectiveness analysis","volume":"5","author":"Okell","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000252658","article-title":"Pharmacokinetic and toxicological profile of artemisinin compounds: an update","volume":"84","author":"Medhi","year":"2009","journal-title":"Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1039\/C4MD00091A","article-title":"Synthesis and evaluation of artesunate-indoloquinoline hybrids as antimalarial drug candidates","volume":"5","author":"Wang","year":"2014","journal-title":"MedChemComm"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bmcl.2015.11.042","article-title":"Synthesis and biological evaluation of a novel artesunate-podophyllotoxin conjugate as anticancer agent","volume":"26","author":"Zhang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2174\/1570180812666141125004502","article-title":"Synthesis of derivatives of artesunate \u03b1-aminophosphonate and their antimicrobial activities","volume":"12","author":"He","year":"2015","journal-title":"Lett. Drug Des. Discov."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3998\/ark.5550190.p008.994","article-title":"Singlet oxygen addition to cyclo-1,3-hexadienes from natural sources and from organocatalytic enal dimerization","volume":"3","author":"Griesbeck","year":"2015","journal-title":"ARKIVOC"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1128\/AAC.05133-11","article-title":"Design and evaluation of primaquine-artemisinin hybrids as a multistage antimalarial strategy","volume":"55","author":"Capela","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1016\/S0968-0896(03)00499-1","article-title":"Artemisinin derivatives bearing Mannich base group: Synthesis and antimalarial activity","volume":"11","author":"Li","year":"2003","journal-title":"Bioorg. Med. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ajoc.201500415","article-title":"Diastereoselective Synthesis of \u03b2-Ether Derivatives of Artemisinin, an Antimalarial Drug: The Effect of Nitrile on Stereoselectivity","volume":"5","author":"Chand","year":"2015","journal-title":"Asian J. Org. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.20450\/mjcce.2012.50","article-title":"Artemisinins and synthetic peroxides as highly efficient antimalarials","volume":"31","author":"Opsenica","year":"2012","journal-title":"Maced. J. Chem. Chem. Eng."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.bmcl.2007.04.054","article-title":"A novel artemisinin-quinine hybrid with potent antimalarial activity","volume":"17","author":"Walsh","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejps.2014.01.014","article-title":"Synthesis and in vitro biological evaluation of aminoacridines and artemisinin-acridine hybrids","volume":"56","author":"Joubert","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1017\/S0031182016000937","article-title":"Pyrrolidine-Acridine hybrid in Artemisinin-based combination: A pharmacodynamic study","volume":"143","author":"Pandey","year":"2016","journal-title":"Parasitology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/AAC.05006-11","article-title":"Synthesis of artemiside and its effects in combination with conventional drugs against severe murine malaria","volume":"56","author":"Guo","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.6023\/cjoc201409039","article-title":"Synthesis and Anti-tumor Effect of Artemisone Derivatives","volume":"35","author":"Wei","year":"2015","journal-title":"Chin. J. Org. Chem."},{"key":"ref_22","first-page":"919","article-title":"Synthesis and Anti-tumor Activities of Novel Artemisone-piperazine-sulfonamide Derivatives","volume":"36","author":"Xu","year":"2015","journal-title":"Chem. J. Chin."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1582-4934.2010.01120.x","article-title":"Design of novel artemisinin-like derivatives with cytotoxic and anti-angiogenic properties","volume":"15","author":"Soomro","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejmech.2015.11.003","article-title":"Synthesis and in vitro antitumor evaluation of dihydroartemisinin-cinnamic acid ester derivatives","volume":"107","author":"Xu","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2875-10-263","article-title":"Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration","volume":"10","author":"Morris","year":"2011","journal-title":"Malar. J."},{"key":"ref_26","unstructured":"World Health Organization (2011). Guidelines for the Treatment of Malaria, World Health Organization."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"148","DOI":"10.5897\/AJPPX12.015","article-title":"Antimalarial drugs: Mode of action and status of resistance","volume":"7","author":"Saifi","year":"2013","journal-title":"Afr. J. Pharm. Pharmacol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0006-2952(94)90287-9","article-title":"Alkylation of proteins by artemisinin. Effects of heme, pH, and drug structure","volume":"48","author":"Yang","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/2141-9248.153609","article-title":"Anticancer Effect of AntiMalarial Artemisinin Compounds","volume":"5","author":"Das","year":"2015","journal-title":"Ann. Med. Health Sci. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1471-4922(00)01838-9","article-title":"Possible modes of action of the artemisinin-type compounds","volume":"17","author":"Olliaro","year":"2001","journal-title":"Trends Parasitol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.bcp.2010.02.016","article-title":"Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells","volume":"80","author":"Lu","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s10637-010-9481-8","article-title":"The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells","volume":"29","author":"Lu","year":"2011","journal-title":"Investig. New Drugs"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1074\/jbc.M110.144188","article-title":"The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials","volume":"286","author":"Mercer","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_34","first-page":"271","article-title":"The Immunologic and Antiviral Effect of Qinghaosu","volume":"2","author":"Qian","year":"1982","journal-title":"J. Tradit. Chin. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.antiviral.2005.10.003","article-title":"The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo","volume":"69","author":"Kaptein","year":"2006","journal-title":"Antivir. Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2217\/nnm.10.71","article-title":"Polymer-drug conjugates for novel molecular targets","volume":"5","author":"Sanchis","year":"2010","journal-title":"Nanomedicine"},{"key":"ref_37","first-page":"83","article-title":"Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl) methacrylamide copolymer doxorubicin]: First member of a new class of chemotherapeutic agents-drug-polymer conjugates","volume":"5","author":"Vasey","year":"1999","journal-title":"Clin. Cancer Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/polc.5070510111","article-title":"Structure and properties of pharmacologically active polymers","volume":"51","author":"Ringsdorf","year":"1975","journal-title":"J. Polym. Sci. C Polym. Symp."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00001813-200104000-00003","article-title":"Phase I clinical and pharmacokinetic study of PNU166945, a novel water-soluble polymer-conjugated prodrug of paclitaxel","volume":"12","author":"Terwogt","year":"2001","journal-title":"Anticancer Drugs"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Liu, K., Dai, L., Li, C., Liu, J., Wang, L., and Lei, J. (2016). Self-assembled targeted nanoparticles based on transferrin-modified eight-arm-polyethylene glycol-dihydroartemisinin conjugate. Sci. Rep., 6.","DOI":"10.1038\/srep29461"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpba.2013.05.001","article-title":"Ternary system of dihydroartemisinin with hydroxypropyl-\u03b2-cyclodextrin and lecithin: Simultaneous enhancement of drug solubility and stability in aqueous solutions","volume":"83","author":"Wang","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1038\/srep05871","article-title":"Novel multiarm polyethylene glycol-dihydroartemisinin conjugates enhancing therapeutic efficacy in non-small-cell lung cancer","volume":"4","author":"Dai","year":"2014","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ejpb.2011.12.007","article-title":"Self-assembled biotransesterified cyclodextrins as Artemisinin nanocarriers\u2014I: Formulation, lyoavailability and in vitro antimalarial activity assessment","volume":"80","author":"Choisnard","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.14233\/ajchem.2013.14449","article-title":"Synthesis of Water Soluble C-10-Phenoxy Artemisinin-Chitosan Conjugate","volume":"25","author":"Xiao","year":"2013","journal-title":"Asian J. Chem."},{"key":"ref_45","first-page":"2736","article-title":"Synthesis and Evaluation of Substituted Poly(organophosphazenes) as a Novel Nanocarrier System for Combined Antimalarial Therapy of Primaquine and Dihydroartemisinin","volume":"32","author":"Kumar","year":"2015","journal-title":"Pharm. Res."},{"key":"ref_46","first-page":"467","article-title":"Pegylated lysine based copolymeric dendritic micelles for solubilization and delivery of artemether","volume":"8","author":"Bhadra","year":"2005","journal-title":"J. Pharm. Pharm. Sci."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Jabbarzadegan, M., Rajayi, H., Mofazzal Jahromi, M.A., Yeganeh, H., Yousefi, M., Muhammad Hassan, Z., and Majidi, J. (2016). Application of arteether-loaded polyurethane nanomicelles to induce immune response in breast cancer model. Artif. Cells Nanomed. Biotechnol., 1\u20139.","DOI":"10.1080\/21691401.2016.1178131"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1021\/mp3002107","article-title":"LyP-1 modification to enhance delivery of artemisinin or fluorescent probe loaded polymeric micelles to highly metastatic tumor and its lymphatics","volume":"9","author":"Wang","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1002\/app.38518","article-title":"In vitro evaluation of efficacy of dihydroartemisinin-loaded methoxy poly (ethylene glycol)\/poly (l-lactic acid) amphiphilic block copolymeric micelles","volume":"128","author":"Lu","year":"2013","journal-title":"J. Appl. Polym. Sci."},{"key":"ref_50","unstructured":"Kim, S., and Park, K. Polymer Micelles for Drug Delivery. Chapter 19. Available online: http:\/\/kinam.com\/Articles\/PMicelles%20Papers\/Kim,%20SW%2010%20Pol%20Micelle%20BookCh.pdf."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Sezer, A.D. (2014). Nanotechnology and Nanomaterials. Application of Nanotechnology in Drug Delivery, Intech.","DOI":"10.5772\/57028"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1039\/C5CC00927H","article-title":"Potential sonodynamic anticancer activities of artemether and liposome-encapsulated artemether","volume":"51","author":"Chen","year":"2015","journal-title":"Chem. Commun."},{"key":"ref_53","first-page":"349","article-title":"Effect of artemisinin liposome and artemisinin liposome polyethyleneglycol on MCF-7 cell line","volume":"2","author":"Neda","year":"2013","journal-title":"Int. J. Life Sci. Biotechnol. Pharm. Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.ejpb.2011.11.015","article-title":"Artemisinin and artemisinin plus curcumin liposomal formulations: Enhanced antimalarial efficacy against Plasmodium berghei-infected mice","volume":"80","author":"Isacchi","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"5591","DOI":"10.1016\/j.biomaterials.2014.03.049","article-title":"Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma","volume":"35","author":"Li","year":"2014","journal-title":"Biomaterials"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/08982104.2010.539185","article-title":"Conventional and long-circulating liposomes of artemisinin: Preparation, characterization, and pharmacokinetic profile in mice","volume":"21","author":"Isacchi","year":"2011","journal-title":"J. Liposome Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2008-2231-22-44","article-title":"Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin","volume":"22","author":"Gharib","year":"2014","journal-title":"DARU J. Pharm. Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/10717544.2013.801047","article-title":"In vivo study of effects of artesunate nanoliposomes on human hepatocellular carcinoma xenografts in nude mice","volume":"20","author":"Jin","year":"2013","journal-title":"Drug Deliv."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s12291-013-0306-3","article-title":"Study of toxicity effect of pegylated nanoliposomal artemisinin on breast cancer cell line","volume":"28","author":"Dadgar","year":"2013","journal-title":"Ind. J. Clin. Biochem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.colsurfb.2013.12.019","article-title":"Strategy to provide a useful solution to effective delivery of dihydroartemisinin: Development, characterization and in vitro studies of liposomal formulations","volume":"116","author":"Righeschi","year":"2014","journal-title":"Colloid Surf. B Biointerfaces"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.nano.2008.12.005","article-title":"Study of artemisinin nanocapsules as anticancer drug delivery systems","volume":"5","author":"Chen","year":"2009","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1208\/s12249-015-0311-3","article-title":"Development and Evaluation of Artesunate-Loaded Chitosan-Coated Lipid Nanocapsule as a Potential Drug Delivery System Against Breast Cancer","volume":"16","author":"Tran","year":"2015","journal-title":"AAPS PharmSciTech"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.colsurfb.2013.11.039","article-title":"Nanocapsules based on mPEGylated artesunate prodrug and its cytotoxicity","volume":"115","author":"Meng","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2147\/IJN.S10907","article-title":"Firstborn microcrystallization method to prepare nanocapsules containing artesunate","volume":"5","author":"Xiao","year":"2010","journal-title":"Int. J. Nanomed."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.nano.2015.07.010","article-title":"In vitro anti-cancer effects of artemisone nano-vesicular formulations on melanoma cells","volume":"11","author":"Dwivedi","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_66","first-page":"67","article-title":"Research Article Artemisinin (ART) Drug Delivery Using Mixed Non-ionic Surfactants and Evaluation of Their Efficiency in Different Cancer Cell Lines","volume":"4","author":"Asgharkhani","year":"2014","journal-title":"Int. J. Drug Deliv. Technol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.2147\/IJN.S83402","article-title":"Compound antimalarial ethosomal cataplasm: Preparation, evaluation, and mechanism of penetration enhancement","volume":"10","author":"Shen","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_68","first-page":"71","article-title":"Nanocapsules: The weapons for novel drug delivery systems","volume":"2","author":"Kothamasu","year":"2012","journal-title":"Bioimpacts"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15806\/j.issn.2311-8571.2016.0002","article-title":"Expanding the Therapeutic Spectrum of Artemisinin: Activity Against Infectious Diseases Beyond Malaria and Novel Pharmaceutical Developments","volume":"2","author":"Effertha","year":"2016","journal-title":"World J. Tradit. Chin. Med."},{"key":"ref_70","first-page":"18","article-title":"Ethosome: A Novel Drug Carrier","volume":"2","author":"Nandure","year":"2013","journal-title":"Int. J. Pharm. Res. Allied Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1021\/nn401196a","article-title":"Carbon-based nanomaterials: Multifunctional materials for biomedical engineering","volume":"7","author":"Cha","year":"2013","journal-title":"ACS Nano"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1007\/s11051-011-0376-1","article-title":"Multiwalled carbon nanotubes effect on the bioavailability of artemisinin and its cytotoxity to cancerous cells","volume":"13","author":"Rezaei","year":"2011","journal-title":"J. Nanopart. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3109\/1061186X.2015.1016437","article-title":"Enhancement of cytotoxicity of artemisinin toward cancer cells by transferrin-mediated carbon nanotubes nanoparticles","volume":"23","author":"Zhang","year":"2015","journal-title":"J. Drug Target."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.biomaterials.2014.10.031","article-title":"Transferrin-mediated fullerenes nanoparticles as Fe2+-dependent drug vehicles for synergistic anti-tumor efficacy","volume":"37","author":"Zhang","year":"2015","journal-title":"Biomaterials"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v26.i6.10","article-title":"Lipid-based nanoparticles as pharmaceutical drug carriers: From concepts to clinic","volume":"26","author":"Puri","year":"2009","journal-title":"Crit. Rev. Ther. Drug Carr. Syst."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Zhang, Y.J., Gallis, B., Taya, M., Wang, S., Ho, R.J., and Sasaki, T. (2013). pH-responsive artemisinin derivatives and lipid nanoparticle formulations inhibit growth of breast cancer cells in vitro and induce down-regulation of HER family members. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059086"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijpharm.2014.03.036","article-title":"Pharmacokinetics study of arteether loaded solid lipid nanoparticles: An improved oral bioavailability in rats","volume":"466","author":"Dwivedi","year":"2014","journal-title":"Int. J. Pharm."},{"key":"ref_78","first-page":"670","article-title":"Dihydroartemisinin loaded nanostructured lipid carriers (DHA-NLC): Evaluation of pharmacokinetics and tissue distribution after intravenous administration to rats","volume":"65","author":"Zhang","year":"2010","journal-title":"Die Pharm. Int. J. Pharm. Sci."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ejps.2010.05.007","article-title":"Arthemeter-loaded lipid nanoparticles produced by modified thin-film hydration: Pharmacokinetics, toxicological and in vivo anti-malarial activity","volume":"40","author":"Aditya","year":"2010","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.colsurfb.2015.04.013","article-title":"Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis","volume":"130","author":"Want","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_81","first-page":"925","article-title":"Formulation and evaluation of nanoparticles containing artemisinin HCL","volume":"3","author":"Gupta","year":"2014","journal-title":"Int. J. Res. Dev. Pharm. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s12272-014-0424-3","article-title":"Enhancing the in vitro anti-cancer efficacy of artesunate by loading into poly-d,l-lactide-co-glycolide (PLGA) nanoparticles","volume":"38","author":"Nguyen","year":"2015","journal-title":"Arch. Pharm. Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.3109\/03639045.2012.658812","article-title":"Artesunate-loaded chitosan\/lecithin nanoparticles: Preparation, characterization, and in vivo studies","volume":"38","author":"Chadha","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jbm.b.33023","article-title":"Enhanced apoptotic effects of dihydroartemisinin-aggregated gelatin and hyaluronan nanoparticles on human lung cancer cells","volume":"102","author":"Sun","year":"2014","journal-title":"J. Biomed. Mater. Res. Part B Appl. Biomater."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ijpharm.2015.09.020","article-title":"Artemisinin nanoformulation suitable for intravenous injection: Preparation, characterization and antimalarial activities","volume":"495","author":"Ibrahim","year":"2015","journal-title":"Int. J. Pharm."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1166\/jbn.2015.2059","article-title":"Biodegradable Core-Shell Copolymer-Phospholipid Nanoparticles for Combination Chemotherapy: An In Vitro Study","volume":"11","author":"Ma","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"ref_87","first-page":"1185","article-title":"Effect of interaction of magnetic nanoparticles of Fe3O4 and artesunate on apoptosis of K562 cells","volume":"6","author":"Wang","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1016\/j.biomaterials.2014.04.028","article-title":"Multifunctional mesoporous nanoparticles as pH-responsive Fe2+ reservoirs and artemisinin vehicles for synergistic inhibition of tumor growth","volume":"35","author":"Chen","year":"2014","journal-title":"Biomaterials"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1039\/c2pp25014d","article-title":"\u03b2-Cyclodextrin polymer nanoparticles as carriers for doxorubicin and artemisinin: A spectroscopic and photophysical study","volume":"11","author":"Anand","year":"2012","journal-title":"Photochem. Photobiol. Sci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1211\/jpp.62.04.0002","article-title":"Dissolution of artemisinin\/polymer composite nanoparticles fabricated by evaporative precipitation of nanosuspension","volume":"62","author":"Kakran","year":"2010","journal-title":"J. Pharm. Pharmacol."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/2\/323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:28:42Z","timestamp":1760207322000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/2\/323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":90,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2]]}},"alternative-id":["molecules22020323"],"URL":"https:\/\/doi.org\/10.3390\/molecules22020323","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,20]]}}}